We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOSS icon
1351
Gossamer Bio
GOSS
$100M
$4.96M 0.01%
572,072
PPYA
1352
DELISTED
Papaya Growth Opportunity Corp. I Class A Common Stock
PPYA
$4.96M 0.01%
+499,998
New +$4.95M
HAIAW
1353
CALL
DELISTED
Healthcare AI Acquisition Corp. Warrants
HAIAW
$4.96M 0.01%
+501,099
New +$151K
NEWT icon
1354
NewtekOne
NEWT
$425M
$4.96M 0.01%
185,593
-124,032
-40% -$3.34M
ABP
1355
DELISTED
Abpro Holdings
ABP
$4.95M 0.01%
+16,667
New +$4.95M
DCRD
1356
DELISTED
Decarbonization Plus Acquisition Corporation IV Class A Ordinary Share
DCRD
$4.94M 0.01%
497,385
BRLT icon
1357
Brilliant Earth
BRLT
$18.4M
$4.94M 0.01%
480,324
+227,249
+90% +$2.59M
EEM icon
1358
PUT
iShares MSCI Emerging Markets ETF
EEM
$28B
$4.94M 0.01%
109,400
-424,300
-80% -$20M
DNLI icon
1359
Denali Therapeutics
DNLI
$3.82B
$4.92M 0.01%
152,855
-231,089
-60% -$7.95M
SOL
1360
DELISTED
Emeren Group
SOL
$4.92M 0.01%
846,457
+89,681
+12% +$529K
CNDA
1361
DELISTED
Concord Acquisition Corp II
CNDA
$4.92M 0.01%
508,032
LCW
1362
DELISTED
Learn CW Investment Corporation Class A Ordinary Shares
LCW
$4.92M 0.01%
498,440
+1,125
+0.2% +$11K
LCAHW
1363
CALL
DELISTED
Landcadia Holdings IV, Inc. Warrant
LCAHW
$4.91M 0.01%
499,997
KT icon
1364
KT
KT
$8.95B
$4.9M 0.01%
341,717
+58,883
+21% +$780K
CLX icon
1365
Clorox
CLX
$12.1B
$4.9M 0.01%
35,234
-22,917
-39% -$3.51M
AIRJW
1366
CALL
AirJoule Technologies Warrant
AIRJW
$61.4M
$4.9M 0.01%
+500,198
New +$242K
ATEK.WS
1367
CALL
DELISTED
Athena Technology Acquisition Corp. II Redeemable Warrants
ATEK.WS
$4.89M 0.01%
+499,998
New +$173K
GHIXW
1368
CALL
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
$4.89M 0.01%
+499,998
New +$317K
PPL
1369
PPL Corp
PPL
$27.3B
$4.89M 0.01%
171,176
-25,688
-13% -$725K
RNAM
1370
DELISTED
Avidity Biosciences
RNAM
$4.89M 0.01%
264,588
RPM icon
1371
RPM International
RPM
$14.3B
$4.88M 0.01%
+59,961
New +$5.15M
USB icon
1372
US Bancorp
USB
$100B
$4.88M 0.01%
91,775
+27,601
+43% +$1.59M
GIAC
1373
DELISTED
Gesher I Acquisition Corp. Class A Ordinary Shares
GIAC
$4.88M 0.01%
495,340
CPAA
1374
DELISTED
Conyers Park III Acquisition Corp. Class A Common Stock
CPAA
$4.87M 0.01%
499,986
GXIIW
1375
CALL
DELISTED
GX Acquisition Corp. II Warrant
GXIIW
$4.87M 0.01%
499,961

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.